MCKESSON CORP shareholders Q2 2023

MCKESSON CORP's ticker is MCK and the CUSIP is 58155Q103. A total of 1,297 filers reported holding MCKESSON CORP in Q2 2023. The put-call ratio across all filers is 1.20 and the average weighting 0.3%.

MCKESSON CORP shareholders Q2 2023
NameSharesValueWeighting ↓
AustralianSuper Pty Ltd 218,768$93,481,7540.59%
WESPAC Advisors, LLC 1,711$731,1270.59%
Achmea Investment Management B.V. 64,705$27,6490.58%
INVESTMENT ADVISORY SERVICES INC /TX /ADV 3,214$1,373,3740.58%
Caerus Investment Advisors, LLC 1,200$512,7720.58%
CHARTER RESEARCH & INVESTMENT GROUP, INC. 1,634$698,2250.58%
INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV 2,629$1,123,3980.58%
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 904,302$386,417,2870.58%
COMMERCE BANK 179,763$76,814,5260.58%
TODD ASSET MANAGEMENT LLC 57,572$24,601,0910.57%
Pensionfund Sabic 4,000$1,7090.57%
AQR Capital Management 633,853$268,443,0960.57%
OSTRUM ASSET MANAGEMENT 15,355$6,561,3450.55%
ELEMENT CAPITAL MANAGEMENT LLC 18,942$8,094,1060.55%
MIRABELLA FINANCIAL SERVICES LLP 11,610$4,961,0690.54%
IAM Advisory, LLC 3,720$1,589,4690.54%
EHP Funds Inc. 5,100$2,179,2810.54%
Copperwynd Financial, LLC 2,681$1,145,8300.53%
Rossmore Private Capital 8,395$3,587,2670.53%
WEDGE CAPITAL MANAGEMENT L L P/NC 77,760$33,227,6260.53%
About MCKESSON CORP

McKesson Corp is a leading healthcare services and information technology company that provides innovative solutions to improve patient care and reduce healthcare costs. The company operates in three segments: pharmaceutical distribution, technology solutions, and medical-surgical solutions.

In the pharmaceutical distribution segment, McKesson is the largest distributor of pharmaceuticals and medical supplies in North America. The company's technology solutions segment provides software and analytics to help healthcare providers improve patient outcomes and reduce costs. The medical-surgical solutions segment offers medical-surgical supplies and equipment to healthcare providers.

McKesson has a strong financial position with a market capitalization of over $30 billion and a revenue of $231 billion in 2020. The company has a diverse customer base, including hospitals, pharmacies, and healthcare providers.

McKesson has been actively involved in the fight against the COVID-19 pandemic. The company has been working with the government and healthcare providers to distribute vaccines and medical supplies to combat the virus. McKesson has also been providing support to healthcare providers by offering telehealth solutions and other digital tools to help them manage patient care remotely.

In conclusion, McKesson Corp is a leading healthcare services and information technology company that is committed to improving patient care and reducing healthcare costs. With its strong financial position and diverse customer base, the company is well-positioned to continue its growth and innovation in the healthcare industry.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists MCKESSON CORP's shareholders in Q2 2023. To view MCKESSON CORP's shareholder history, click here.